HuagongsheHuagongshe Chemistry Print Report · For research reference only
benzyl (2S)-2-amino-3-methylbutanoate → HCID 11285398, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | benzyl (2S)-2-amino-3-methylbutanoate | HCID 6950584 | — |
| Reactant | 5-(4'-(Bromomethyl)(1,1'-biphenyl)-2-yl)-1-trityl-1H-tetraazole | HCID 10053461 | — |
| Reactant | HCID 178447302 | HCID 178447302 | — |
| Product | HCID 11285398 | HCID 11285398 | — |
Reaction Steps
According to U.S. Pat. No. 5,399,578, Valsartan can also be prepared by reaction of 4-bromomethyl-2′-(1-triphenylmethyltetrazol-5-yl)biphenyl (VI) with L-valine benzyl ester to produce N-[[2′-(1-triphenylmethyltetrazol-5-yl)biphenyl-4-yl]-methyl]-L-valine benzyl ester (VII), followed by treatment with valeryl chloride to produce N-(1-oxopentyl)-N-[[2′-(1-triphenylmethyltetrazol-5-yl)[1,1′-biphenyl]-4-yl]-methyl]-L-valine benzyl ester (VIII). Compound (VIII) is deprotected under acidic conditions to produce N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]-methyl]-L-valine benzyl ester (IX), which is then hydrogenated in presence of Pd/C catalyst to give finally Valsartan. The process is shown in scheme II, below:
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07880015B2 |
| Source dataset | uspto-grants-2011_02 |
| ORD ID | ord-904d09ad5c084e2b95404db93c776664 |
| Source note | uspto-grants-2011_02 |